Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter s Q4 Revenues Increase 9 Percent

NEW YORK, Jan. 28 (GenomeWeb News) - Beckman Coulter today reported revenues of $694 million for the quarter ending Dec. 31, an increase of 9 percent over $639 million for the year-ago period.

 

Beckman's net earnings for the period were $60 million, down 15 percent from last year's $70 million in the fourth quarter.

 

The company said the drop in its net revenues was a consequence of growing sales of its diagnostic instrument systems, which should result in increased revenue in the future from the consumption of aftermarket test kits, the company said. Beckman did not give a time frame to expect the growth to come.

 

Beckman reported R&D expenditures of $54 million for the quarter, compared to $55 million for the year-ago quarter.

 

The company had cash and cash equivalents of $68 million as of Dec. 31.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.